Limbal Allograft, Amniotic Membrane Transplantation, and Intraoperative Mitomycin C for Recurrent Pterygium
To conduct a pilot study evaluating the efficacy and safety of limbal allograft, preserved amniotic membrane transplantation, and intraoperative mitomycin C treatment for recurrent pterygium. Prospective, noncomparative, interventional case series. Twelve eyes of 11 patients with recurrent pterygium...
Saved in:
Published in | Ophthalmology Vol. 112; no. 7; pp. 1263 - 1267 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
New York, NY
Elsevier Inc
01.07.2005
Elsevier BV Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | To conduct a pilot study evaluating the efficacy and safety of limbal allograft, preserved amniotic membrane transplantation, and intraoperative mitomycin C treatment for recurrent pterygium.
Prospective, noncomparative, interventional case series.
Twelve eyes of 11 patients with recurrent pterygium. The mean number of previous surgeries for pterygium was 1.9±1.4 (range, 1–6).
All subjects received limbal allograft, preserved amniotic membrane transplantation, and intraoperative mitomycin C.
Pterygium recurrence and complications.
The mean follow-up period was 21.6±5.6 months (range, 16–36 months). There was no pterygium recurrence in any of the eyes. Symblepharon reappeared in 3 eyes and diplopia recurred in 2 eyes. There were no other surgical complications and there was no graft rejection.
Limbal allograft, preserved amniotic membrane transplantation, and intraoperative mitomycin C may be a safe and effective procedure for recurrent pterygium. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0161-6420 1549-4713 1549-4713 |
DOI: | 10.1016/j.ophtha.2005.01.037 |